We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

76 hedge funds and large institutions have $135M invested in Immunomedics Inc in 2014 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 18

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

1% more funds holding

Funds holding: 75 → 76 (+1)

5% less capital invested

Capital invested by funds: $143M → $135M (-$7.78M)

34% less call options, than puts

Call options by funds: $2.91M | Put options by funds: $4.4M

Holders
76
Holders Change
+1
Holders Change %
+1.33%
% of All Funds
2.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
32
Reduced
18
Closed
6
Calls
$2.91M
Puts
$4.4M
Net Calls
-$1.49M
Net Calls Change
+$755K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.56M
2
RCM
RA Capital Management
Massachusetts
+$3.67M
3
SFM
Sphera Funds Management
Israel
+$918K
4
DM
Deerfield Management
New York
+$650K
5
TC
TFS Capital
Pennsylvania
+$600K

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$793K
2
Prudential Financial
Prudential Financial
New Jersey
-$278K
3
Goldman Sachs
Goldman Sachs
New York
-$215K
4
ProShare Advisors
ProShare Advisors
Maryland
-$153K
5
Deutsche Bank
Deutsche Bank
Germany
-$151K
Name Holding Trade Value Shares
Change 		Change in
Stake
OC
26
Oppenheimer & Co
New York
$382K +$42.6K +11,600 +12%
State Board of Administration of Florida Retirement System
27
State Board of Administration of Florida Retirement System
Florida
$375K – – –
Allianz Asset Management
28
Allianz Asset Management
Germany
$365K – – –
Morgan Stanley
29
Morgan Stanley
New York
$360K +$4.99K +1,358 +1%
ProShare Advisors
30
ProShare Advisors
Maryland
$352K -$153K -41,594 -30%
Swiss National Bank
31
Swiss National Bank
Switzerland
$349K +$27.7K +7,550 +9%
Group One Trading
32
Group One Trading
Illinois
$338K -$104K -28,297 -23%
AQR Capital Management
33
AQR Capital Management
Connecticut
$307K +$4.41K +1,200 +1%
CS
34
Credit Suisse
Switzerland
$300K -$119K -32,334 -28%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$249K +$15.7K +4,288 +7%
NFA
36
Nationwide Fund Advisors
Ohio
$231K +$25.3K +6,904 +12%
VOYA Investment Management
37
VOYA Investment Management
Georgia
$225K – – –
MLICM
38
Metropolitan Life Insurance Company (MetLife)
New York
$224K – – –
Manulife (Manufacturers Life Insurance)
39
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$207K -$3.94K -1,072 -2%
AIG
40
American International Group
New York
$203K +$21.5K +5,853 +12%
BA
41
BlackRock Advisors
Delaware
$196K -$5.9K -1,608 -3%
DekaBank Deutsche Girozentrale
42
DekaBank Deutsche Girozentrale
Germany
$194K +$5.51K +1,500 +3%
DIA
43
Denver Investment Advisors
Colorado
$180K +$91.7K +24,976 +102%
Public Employees Retirement Association of Colorado
44
Public Employees Retirement Association of Colorado
Colorado
$176K – – –
Citadel Advisors
45
Citadel Advisors
Florida
$161K -$26.8K -7,302 -14%
Barclays
46
Barclays
United Kingdom
$158K -$147K -40,133 -43%
CIA
47
Capital Impact Advisors
Massachusetts
$158K +$159K +43,323 New
T. Rowe Price Associates
48
T. Rowe Price Associates
Maryland
$156K +$47.7K +13,000 +44%
UBS AM
49
UBS AM
Illinois
$113K – – –
FHC
50
First Heartland Consultants
Missouri
$112K – – –
1
2
3 4

IMMU Hedge Fund Activity: Q2 2014 in Review

76 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q2 2014, worth a combined $135M — down 5.4% from $143M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new IMMU positions and 6 closed out — a net gain of 1 holder — while 32 added to existing stakes and 18 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $4.56M. The largest seller was Wellington Management Group, exiting entirely with an estimated $793K sold.

  • 76 institutional investors held Immunomedics Inc (IMMU) as of Q2 2014, up from 75 in Q1 2014.
  • Funds reported $135M of Immunomedics Inc stock for Q2 2014, down 5.4% quarter-over-quarter.
  • 7 funds opened new Immunomedics Inc positions in Q2 2014 and 6 closed out, a net change of +1 holder.
  • The largest Immunomedics Inc buyer in Q2 2014 was Fidelity Investments, an estimated $4.56M added.
  • The largest Immunomedics Inc seller in Q2 2014 was Wellington Management Group, an estimated $793K sold.

Based on aggregated 13F filings for Q2 2014.